US FDA to phase out animal testing in drug development
Go back to US FDA to phase out animal testing in drug development| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 290.19 +3.36 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $286.83 | 52 Week High | $89.18 | |||
| Open | $287.91 | 52 Week Low | $65.70 | |||
| Day High | $290.61 | P/E | 134.97 | |||
| Day Low | $285.75 | EPS | $2.15 | |||
| Volume | 445,725 | |||||
